Quanterix is a brand at the forefront of biomarker detection innovation. With their revolutionary bead-based immunoassay technology, they have enabled the measurement of biomarkers at lower levels than ever before, leading to earlier disease detection. Their flagship product, Simoa® Technology, has set the gold standard for biomarker detection in blood, serum, or plasma, allowing researchers to quantify proteins at levels far lower than the Level of Quantification (LoQ).

Quanterix offers a range of products and services to support biomarker research and diagnostics. Their Simoa® Assay Kits, compatible with Quanterix instruments, provide ready-to-use solutions for ultrasensitive biomarker measurement. They also offer the HD-X™ Automated Immunoassay Analyzer, the SR-X™ Biomarker Detection System, and the SP-X Imaging and Analysis System™, which are state-of-the-art instruments for accurate biomarker detection.

In addition to their instrumental offerings, Quanterix provides a full-service center for biomarker testing services and custom immunoassay development through their Simoa® Accelerator Laboratory. They also offer Uman NF-Light™ ELISA kits and antibodies for detecting neurofilament light chain, as well as a Homebrew – Custom Assay Development solution for specialized research applications. With Quanterix's ultrasensitive biomarker detection technology and comprehensive support and resources, researchers and clinicians have the tools they need to advance disease understanding and management in neurology, oncology, immunology, cardiology, and infectious disease.

From discovery to diagnostics, Quanterix is transforming the field of biomarker research with unparalleled sensitivity and flexibility. Their Simoa® Technology allows scientists to measure biomarkers at levels never before achievable, fueling breakthroughs in disease detection and management. Whether it's their bead-based immunoassay technology or their planar array technology, Quanterix offers unique capabilities for detecting and quantifying critical proteins and nucleic acids at ultra low levels in common sample types.

Their range of instruments, including the HD-X™ Automated Immunoassay Analyzer, the SR-X™ Biomarker Detection System, and the SP-X Imaging and Analysis System™, provide researchers with the tools they need for robust multiplex biomarker detection. These instruments offer up to 1000x greater sensitivity, allowing for the measurement of up to 10 biomarkers in a single assay. Quanterix's commitment to innovation extends beyond instrumental offerings.

They also provide a full-service Simoa® Accelerator Laboratory for biomarker testing services and custom immunoassay development. With this laboratory, researchers can expand the limits of biomarker exploration and accelerate the timeline to drug approvals. With Quanterix, researchers have a partner that is driving advancements in biomarker detection, supporting their research with precision instruments, and delivering groundbreaking solutions that push the boundaries of what is possible in disease understanding and management